Efficacy of intermediate-dose oral erythromycin on very low birth weight infants with feeding intolerance

Pediatrics and Neonatology

Volumn 53, Issue 1, 2012, Pages 34-40

  Ng, Yan Yan ^a   Su, Pen Hua ^a,b   Chen, Jia Yuh ^a,b   Quek, Yeak Wun ^a   Hu, Jui Ming ^a,b   Lee, Inn Chi ^a   Lee, Hong Shen ^b   Chang, Hua Pin ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

feeding intolerance; oral erythromycin; very low birth weight infants

Indexed keywords

ERYTHROMYCIN ESTOLATE;

ARTICLE; BODY WEIGHT; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ENTERIC FEEDING; FEEDING DISORDER; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTROPHIC PYLORUS STENOSIS; INCIDENCE; INFANT; LUNG DYSPLASIA; MALE; NECROTIZING ENTEROCOLITIS; PARENTERAL NUTRITION; RETROLENTAL FIBROPLASIA; SEPSIS; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, ORAL; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS; WEIGHT GAIN;

EID: 84862829841     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2011.11.007     Document Type: Article

References (34)

1. G. Mhairi, M.K. Mary, and D. Martha Nutrition Avery's Neonatology 6th ed. 2005 Lippincott, Williams & Wilkins Philadelphia 378 412
2. E. Ng, and V.S. Shah Erythromycin for the prevention and treatment of feeding intolerance in preterm infants Cochrane Database Syst Rev 3 2008 CD001815
3. S. Patole, S. Rao, and D. Doherty Erythromycin as a prokinetic agent in preterm neonates: a systematic review Arch Dis Child Fetal Neonatal Ed 90 2005 F301 F306
4. D.A. Kelly Liver complications of pediatric parenteral nutrition: epidemiology Nutrition 14 1998 153 157 (Pubitemid 28049003)
5. R.A. Drongowski, and A.G. Coran An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis J Parenter Enteral Nutr 13 1989 586 589 (Pubitemid 20005554)
6. G.A. Kullak-Ublick Meier PJ. Mechanisms of cholestasis Clin Liver Dis 4 2000 357 385
7. M.H. Hsieh, W. Pai, H.I. Tseng, S.N. Yang, C.C. Lu, and H.L. Chen Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors Pediatr Neonatol 50 2009 202 207
8. V. Bozzetti, and P. Tagliabue Metabolic bone disease in preterm newborn: an update on nutritional issues Ital J Pediatr 35 2009 20
9. S. Patole Strategies for prevention of feed intolerance in preterm neonates: a systematic review J Matern Fetal Neonatal Med 18 2005 67 76 (Pubitemid 41226459)
10. K.K. Collins, and J.M. Sondheimer Domperidone-induced QT prolongation: add another drug to the list J Pediatr 153 2008 596 598
11. A. Dubin, M. Kikkert, M. Mirmiran, and R. Ariagno Cisapride associated with QTc prolongation in very low birth weight preterm infants Pediatrics 107 2001 1313 1316 (Pubitemid 32525208)
12. U. Yis, D. Ozdemir, M. Duman, and N. Unal Metoclopramide induced dystonia in children: two case reports Eur J Emerg Med 12 2005 117 119
13. A.M. Hibbs, and S.A. Lorch Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review Pediatrics 118 2006 746 752 (Pubitemid 46085434)
14. S.C. Reddymasu, I. Soykan, and R.W. McCallum Domperidone: review of pharmacology and clinical applications in gastroenterology Am J Gastroenterol 102 2007 2036 2045 (Pubitemid 47301500)
15. J. Frackx, and P. Noel Acute extrapyramidal dysfunction after domperidone administration: report of a case Helv Paediatr Acta 39 1984 285 288 (Pubitemid 14057235)
16. B. Drolet, G. Rousseau, P. Daleau, R. Cardinal, and J. Turgeon Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders Circulation 102 2000 1883 1885
17. C.M. Rocha, and M.M. Barbosa QT interval prolongation associated with the oral use of domperidone in an infant Pediatr Cardiol 26 2005 720 723 (Pubitemid 43015826)
18. C.V. Hawkyard, and R.J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J Antimicrob Chemother 59 2007 347 358 (Pubitemid 47073441)
19. T.L. Peeters Erythromycin and other macrolides as prokinetic agents Gastroenterology 105 1993 1886 1899 (Pubitemid 24002809)
20. C. Di Lorenzo, A.F. Flores, T. Tomomasa, and P.E. Hyman Effect of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms Dig Dis Sci 39 1994 1399 1404 (Pubitemid 24246426)
21. S.R. Jadcherla, G. Klee, and C.L. Berseth Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants Pediatr Res 42 1997 365 369 (Pubitemid 27362734)
22. B.J. Stenson, L. Middlemist, and A.J. Lyon Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial Arch Dis Child Fetal Neonatal Ed 79 1998 F212 F214
23. P. Cairns, S. Craig, R. Tubman, R.S. Roberts, J. Wilson, and B. Schmidt Randomised controlled trial of low-dose erythromycin in preterm infants with feed intolerance Arch Dis Child 86 2002 14 20
24. B.H. Su, H.C. Lin, C.T. Peng, and C.H. Tsai Effect of erythromycin on feeding intolerance in very low birth weight infants: a preliminary observation Acta Paed Sin 39 1998 324 326
25. J. Oei, and K. Lui A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants Acta Paediatr 90 2001 904 908 (Pubitemid 32762838)
26. S.K. Patole, R. Almonte, R. Kadalraja, R. Tuladhar, R. Muller, and J.S. Whitehall Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates? Int J Clin Pract 54 2000 504 508
27. H. Aly, H. Abdel-Hady, M. Khashaba, and N. El-Badry Erythromycin and feeding intolerance in premature infants: a randomized trial J Perinatol 27 2007 39 43 (Pubitemid 44971051)
28. P. Nuntnarumit, P. Kiatchoosakun, W. Tantiprapa, and S. Boonkasidecha Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants J Pediatr 148 2006 600 605 (Pubitemid 43776898)
29. P.C. Ng, K.W. So, and K.S. Fung Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants Arch Dis Child Fetal Neonatal Ed 84 2001 F177 F182
30. M.A. Honein, L.J. Paulozzi, and I.M. Himelright Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study Lancet 354 1999 2101 2105 (Pubitemid 30008892)
31. W.O. Cooper, M.R. Griffin, P. Arbogast, G.B. Hickson, S. Gautam, and W.A. Ray Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis Arch Pediatr Adolesc Med 156 2002 647 650 (Pubitemid 34755991)
32. M. Hauben, and G.W. Amsden The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Drug Saf 25 2002 929 942 (Pubitemid 35252718)
33. Y. Shiima, H. Tsukahara, R. Kobata, K. Hayakawa, M. Hiraoka, and M. Mayumi Erythromycin in ELBW infants J Pediatr 141 2002 297 298
34. S.K. Patole, R. Kadalraja, R. Tuladhar, R. Almonte, R. Muller, and J.S. Whitehall Benefits of a standardised feeding regimen during a clinical trial in preterm neonates Int J Clin Pract 54 2000 429 431